Matt Mealiffe
About
In The Last Decade
Matt Mealiffe
2 papers receiving 97 citations
Peers
Comparison fields: 5 of 17
- Nephrology 91
- Oncology 39
- Rheumatology 31
- Nutrition and Dietetics 30
- Pulmonary and Respiratory Medicine 22
Countries citing papers authored by Matt Mealiffe
This map shows the geographic impact of Matt Mealiffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Mealiffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Mealiffe more than expected).
Fields of papers citing papers by Matt Mealiffe
This network shows the impact of papers produced by Matt Mealiffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Mealiffe. The network helps show where Matt Mealiffe may publish in the future.
Co-authorship network of co-authors of Matt Mealiffe
This figure shows the co-authorship network connecting the top 25 collaborators of Matt Mealiffe. A scholar is included among the top collaborators of Matt Mealiffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt Mealiffe. Matt Mealiffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 97 | |
| 2 | A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF BUROSUMAB, AN ANTI-FGF23 ANTIBODY, IN ADULT X-LINKED HYPOPHOSPHATEMIA (XLH) | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.